sellWeak10b5-1 plan
Stephen K. Brannan sold $4.8M of KRTX
Chief Medical Officer at Karuna Therapeutics, Inc.. 15,000 shares at an average of $316.81, traded Jan 8, 2024, filed Jan 9, 2024.
Warning score
15Value
$4.8M
15,000 shares
Holdings after
38,650
-28% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$4.8M at market
- +10Share of holdings soldSold 28% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-003372, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 8, 2024 | MOption exercise Common Stock10b5-1 | +2,500 | $5.45 | $14k | 38,650 | Jan 9, 2024 |
| Jan 8, 2024 | MOption exercise Common Stock10b5-1 | +5,304 | $131.64 | $698k | 43,954 | Jan 9, 2024 |
| Jan 8, 2024 | MOption exercise Common Stock10b5-1 | +9,696 | $111.97 | $1.1M | 53,650 | Jan 9, 2024 |
| Jan 8, 2024 | SOpen-market sale Common Stock10b5-1 | -15,000 | $316.81 | $4.8M | 38,650 | Jan 9, 2024 |
| Jan 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 9,677 | Jan 9, 2024 |
| Jan 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -5,304 | $0.00 | $0 | 16,046 | Jan 9, 2024 |
| Jan 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -9,696 | $0.00 | $0 | 44,604 | Jan 9, 2024 |
Related signals
Other insiders at Karuna Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $2.0M 10,000 shares | -22% | |
| 8Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $889k 5,000 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.